After a steep drop in Trump’s popularity following the tariff nightmare of Liberation Day, he’s back where he was for most of ...

Breast cancer is the most common cancer in women in the United States, except for skin cancers. It accounts for about 30% (or 1 in 3) of all new female cancers each year. The American Cancer Society's ...

Janux Therapeutics, Inc. (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its Tumor Activated T Cell ...

The development of second tumors is influenced by several factors. These include the type and intensity of treatment received ...

The tough challenge carried a simple but important message – Hi lads, get your prostate checked. Joe, a prostate cancer survivor, personally benefited from the support of Cancer Care West throughout ...

People who pay more in taxes could be less likely to die from cancer. The link was revealed in a new study published in JAMA Network Open, which aimed to explore how state-level tax revenue ...

These days, many support groups meet virtually, so these helpful connections can be made from the comfort of your own home. In a previous conversation with SurvivorNet, ovarian cancer survivor Annie ...

On National Melanoma Day, which is recognized on the first Monday of May, we speak with a cancer survivor who is sharing her journey with our viewers. Colleen Birch is being honored by the ...

A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads. A clinical study of ovarian and colorectal cancer patients found cancer cells move ...

During interviews at the American Association for Cancer Research (AACR) Annual Meeting 2025, experts shared key insights from this ... The inclusion of the survivor advocate program, I think ...

"Here's How I Knew I Had Cervical Cancer": One Survivor's Story of Discovering Unexpected Symptoms "Here's How I Knew I Had Prostate Cancer": One Patient's Story of ...

It was the chance of a lifetime for a young boy who has been through so much. Just a few weeks after finishing treatment for a very rare pediatric brain cancer, 12-year-old Fletcher Rollinson, a ...